Evidence map›Paper›PMID 26757934›Full record

ArticleInternational ophthalmology2016

A very rare case of eyelid metastasis originating from lung adenocarcinoma.

Mehdi Tavakoli, Mahsan Assadi, Mohammad Hassan Seifi, Bahareh Behdad, Hossein Salour

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mehdi TavakoliOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Paidarifard St., Pasdaran Ave., Tehran, 16666, Iran. mehditavakolimd@yahoo.com.ORCID http://orcid.org/0000-0002-4828-2313
Mahsan AssadiOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Paidarifard St., Pasdaran Ave., Tehran, 16666, Iran.
Mohammad Hassan SeifiOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Paidarifard St., Pasdaran Ave., Tehran, 16666, Iran.
Bahareh BehdadOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Paidarifard St., Pasdaran Ave., Tehran, 16666, Iran.
Hossein SalourOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Paidarifard St., Pasdaran Ave., Tehran, 16666, Iran.
Shahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report a very rare eyelid mass confirmed to be a metastasis from lung adenocarcinoma.

methodsA 68-year-old man had a two-month history of a large nodule in the right upper eyelid. He was a known case of lung adenocarcinoma since 2 years without a history of systemic metastasis. He underwent further investigations including orbital imaging and biopsy of the lesion.

resultsBiopsy and immunohistochemical evaluations of the eyelid lesion revealed a moderate to poorly differentiated adenocarcinoma, a similar histology to the lung lesion.

conclusionsMetastatic involvement of the eyelids is rarely seen; specifically, those associated with lung adenocarcinoma as the source have been reported extremely rare. Eyelid metastases present with various and non-specific clinical features, and therefore biopsy of suspicious or recurrent lesions is highly recommended to rule out such malignant processes.

Indexed as

AdenocarcinomaAgedBiomarkers, TumorEyelid NeoplasmsHumansImmunohistochemistryLung NeoplasmsMaleNeoplasm ProteinsBiomarkers, TumorNeoplasm ProteinsAdenocarcinomaEyelid lesionEyelid metastasisLung carcinoma

Identifiers

PMID26757934
OpenAlexW2234731041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.